Annual report pursuant to Section 13 and 15(d)

RFS Pharma, LLC Acquisition (Details Narrative)

v3.7.0.1
RFS Pharma, LLC Acquisition (Details Narrative) - USD ($)
$ in Thousands
Nov. 25, 2014
Dec. 31, 2016
Dec. 31, 2015
Mar. 03, 2015
Proceeds from issuance of options $ 184,800      
Common stock, shares authorized   800,000,000 800,000,000 800,000,000
RFS Pharma, LLC [Member]        
Number of options to purchase of common stock, shares 16,542,538      
Proceeds from issuance of options $ 6,600      
RFS Pharma, LLC [Member] | Series A Preferred Stock [Member]        
Number of options to purchase of common stock, shares 1,000,000      
Proceeds from issuance of options $ 178,200      
Number of converted shares of common stock 340,760,802      
Common stock, shares authorized 800,000,000